-
What Happened When an Indian Drug Company Offered Affordable AIDS Medication
Indian scientist Dr. Yusuf Hamied's proposal to cheaply manufacture and sell life-saving AIDS medications makes him "one of the great individuals of the 21st century".
-
The Global Battle Over High Drug Prices Opens in a new window)
These days it is hard to find a government that is not struggling with the high price of medicines.
-
Push for Drug Pricing Transparency Strikes a Nerve With Industry Opens in a new window)
Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around drug pricing has already ruffled feathers.
-
Scrip Q1 2019 Sales and Earnings
Scrip analysts dissect Q1 sales and earnings reports of top pharma companies and focus on key trends, developments, and projected future impact.
-
US Drug Pricing is in Need of an Overhaul Opens in a new window)
The structure of the market suits everyone involved, except for ill Americans.
-
Health Care CEOs Took Home $2.6 Billion in 2018 Opens in a new window)
Pharma CEOs represented 11 of the 25 highest compensation amounts.
-
Doctors Are Running Out of Effective Drugs Because of Poor Financial Incentives to Develop Them Opens in a new window)
In some cases, doctors have no drugs to give their patients for what once were treatable infections but are now life-threatening.
-
Harnessing The Patient Voice in Real-World Evidence: The Essential Role of Patient-Reported Outcomes Opens in a new window)
Real-world evidence is increasingly valued by regulators and payers.
-
Harnessing The Patient Voice in Real-World Evidence Opens in a new window)
The essential role of patient-reported outcomes.
-
The Intersection of Race and Blood Opens in a new window)
Blood can be racially or ethnically specific.
-
Drugmakers Getting Richer Opens in a new window)
Twelve of the most profitable drug companies in Q1 collectively reported more than $29 billion in profits.
-
'Bottle Of Lies' Exposes The Dark Side Of The Generic Drug Boom Opens in a new window)
Investigative journalist and author Katherine Eban exposes the dangerous, dark side of some generics.
-
Building New Models To Support The Ailing Antibiotics Market Opens in a new window)
-
Softening the Language Used to Describe Drug Pricing Opens in a new window)
Pharma pushes back against setting international standards for drug-pricing transparency.
-
How a Wikipedia for Drug Discovery is Disrupting Big Pharma Opens in a new window)
What if there was another way of developing the medicines we need?
